BioNet News, Covid-19, Press Releases 21 Mar 2022 Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines. Supachai
BioNet News, Covid-19, Press Releases 18 Jan 2022 COVALIA study update: Interim Safety Results from needle-free SARS-CoV2 DNA vaccine phase 1 trial Melbourne 17 January 2022 –Technovalia, an Australian biotech vaccine developer today announced the interim safety results of the ongoing phase… Supachai
Australia, Biotech News, Covid-19 24 Sep 2020 University of Sydney to advance COVID-19 DNA vaccine to human trials The University of Sydney is testing a novel DNA-based COVID-19 vaccine with the goal of being administered using a needle-free… Supachai